Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29(2):181–191. https://doi.org/10.1016/S0002-9378(15)30642-6
Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31(12):2841–2855. https://doi.org/10.1093/humrep/dew218
Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO (2016) Polycystic ovary syndrome. Nat Rev Dis Primers 216057. https://doi.org/10.1038/nrdp.2016.57
Macut D, Antić IB, Bjekić-Macut J (2015) Cardiovascular risk factors and events in women with androgen excess. J Endocrinol Invest 38(3):295–301. https://doi.org/10.1007/s40618-014-0215-1
Article PubMed CAS Google Scholar
De Leo V, Musacchio M, Cappelli V, Massaro M, Morgante G, Petraglia F (2016) Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol 14(1):1–17. https://doi.org/10.1186/s12958-016-0173-x
Oguz SH, İdilman I, Helvaci N, Guzelce EC, Eyupoglu D, Karcaaltincaba M et al (2020) Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome. Reprod Biomed Online 41(2):329–334. https://doi.org/10.1016/j.rbmo.2020.04.024
Article PubMed CAS Google Scholar
Sarkar M, Terrault N, Chan W, Cedars MI, Huddleston HG, Duwaerts CC et al (2020) Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis. Liver Int 40(2):355–359. https://doi.org/10.1111/liv.14279
Article PubMed CAS Google Scholar
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W et al (2006) Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 91(11):4237–4245. https://doi.org/10.1210/jc.2006-0178
Article PubMed CAS Google Scholar
Cinar N, Kizilarslanoglu MC, Harmanci A, Aksoy DY, Bozdag G, Demir B et al (2011) Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod 26(12):3339–3345. https://doi.org/10.1093/humrep/der338
Cooney LG, Lee I, Sammel MD, Dokras A (2017) High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 32(5):1075–1091. https://doi.org/10.1093/humrep/dex044
Shan D, Han J, Cai Y, Zou L, Xu L, Shen Y (2022) Reproductive health in first-degree relatives of patients with polycystic ovary syndrome: a review and meta-analysis. J Clin Endocrinol Metab 107(1):273–295. https://doi.org/10.1210/clinem/dgab640
Yilmaz B, Vellanki P, Ata B, Yildiz BO (2018) Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Ster 109(2):356–364e32. https://doi.org/10.1016/j.fertnstert.2017.10.018
Yilmaz B, Vellanki P, Ata B, Yildiz BO (2018) Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Ster 110(3):523–533e14. https://doi.org/10.1016/j.fertnstert.2018.04.024
Helvaci N, Yildiz BO (2022) The impact of ageing and menopause in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 97(3):371–382. https://doi.org/10.1111/cen.14558
Vanky E, Løvvik TS (2020) Polycystic ovary syndrome and pregnancy– from a clinical perspective. Curr Opin Endocr Metab Res 12:8–13. https://doi.org/10.1016/j.coemr.2020.01.005
Vanky E, Engen Hanem LG, Abbott DH (2019) Children born to women with polycystic ovary syndrome-short- and long-term impacts on health and development. Fertil Ster 111(6):1065–1075. https://doi.org/10.1016/j.fertnstert.2019.03.015
Barrett ES, Hoeger KM, Sathyanarayana S, Abbott DH, Redmon JB, Nguyen RH et al (2018) Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure. J Dev Orig Health Dis 9(3):307–314. https://doi.org/10.1017/S2040174417001118
Article PubMed PubMed Central CAS Google Scholar
Homburg R, Gudi A, Shah A, Layton M A (2017) A novel method to demonstrate that pregnant women with polycystic ovary syndrome hyper-expose their fetus to androgens as a possible stepping stone for the developmental theory of PCOS. A pilot study. Reprod Biol Endocrinol 15:1–4. https://doi.org/10.1186/s12958-017-0282-1
Finnbogadóttir SK, Glintborg D, Jensen TK, Kyhl HB, Nohr EA, Andersen M (2017) Insulin resistance in pregnant women with and without polycystic ovary syndrome, and measures of body composition in offspring at birth and three years of age. Acta Obstet Gynecol Scand 96(11):1307–1314. https://doi.org/10.1111/aogs.13200
Article PubMed CAS Google Scholar
Hanem LGE, Salvesen Ø, Juliusson PB, Carlsen SM, Nossum MCF, Vaage MØ et al (2019) Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5–10 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health 3(3):166–174. https://doi.org/10.1016/S2352-4642(18)30385-7
Bell GA, Sundaram R, Mumford SL, Park H, Broadney M, Mills JL et al (2018) Maternal polycystic ovarian syndrome and offspring growth: the Upstate KIDS Study. J Epidemiol Community Health 72(9):852–855. https://doi.org/10.1136/jech-2017-210004
de Wilde MA, Eising JB, Gunning MN, Koster MP, Evelein AM, Dalmeijer GW et al (2018) Cardiovascular and metabolic health of 74 children from women previously diagnosed with polycystic ovary syndrome in comparison with a population-based reference cohort. Reprod Sci 25:1492–1500. https://doi.org/10.1177/1933719117749761
Sir-Petermann T, Codner E, Maliqueo M, Echiburu B, Hitschfeld C, Crisosto N et al (2006) Increased anti-mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 91(8):3105–3109. https://doi.org/10.1210/jc.2005-2693
Article PubMed CAS Google Scholar
Sir-Petermann T, Codner E, Pérez V, Echiburú B, Maliqueo M, Ladron de Guevara A et al (2009) Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 94(6):1923–1930. https://doi.org/10.1210/jc.2008-2836
Article PubMed PubMed Central CAS Google Scholar
Crisosto N, Codner E, Maliqueo M, Echiburu B, Sanchez F, Cassorla F et al (2007) Anti-mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 92(7):2739–2743. https://doi.org/10.1210/jc.2007-0267
Article PubMed CAS Google Scholar
Legro RS, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Brindle E et al (2017) Normal pubertal development in daughters of women with PCOS: a controlled study. J Clin Endocrinol Metab 102(1):122–131. https://doi.org/10.1210/jc.2016-2707
Sir-Petermann T, Guevara ALd, Codner E, Preisler J, Crisosto N, Echiburú B et al (2012) Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome. Reprod Sci 19(4):383–390. https://doi.org/10.1177/1933719111424444
Article PubMed CAS Google Scholar
Recabarren SE, Sir-Petermann T, Rios R, Maliqueo M, Echiburu B, Smith R et al (2008) Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood. J Clin Endocrinol Metab 93(9):3318–3324. https://doi.org/10.1210/jc.2008-0255
Article PubMed CAS Google Scholar
Crisosto N, Echiburú B, Maliqueo M, Luchsinger M, Rojas P, Recabarren S et al (2017) Reproductive and metabolic features during puberty in sons of women with polycystic ovary syndrome. Endocr Connect 6(8):607–613. https://doi.org/10.1530/EC-17-0218
Article PubMed PubMed Central CAS Google Scholar
Recabarren SE, Smith R, Rios R, Maliqueo M, Echiburu B, Codner E et al (2008) Metabolic profile in sons of women with polycystic ovary syndrome. J Clin Endocrinol Metab 93(5):1820–1826. https://doi.org/10.1210/jc.2007-2256
留言 (0)